These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 18788616

  • 1. [Characterization and functional studies of vWF A3 domain monoclonal antibodies that inhibit binding of vWF to collagen].
    Zhao YM, Dong NZ, Shen F, Xie LQ, Ruan CG.
    Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):171-4. PubMed ID: 18788616
    [Abstract] [Full Text] [Related]

  • 2. Two novel monoclonal antibodies to VWFA3 inhibit VWF-collagen and VWF-platelet interactions.
    Zhao Y, Dong N, Shen F, Xie L, He Y, Liu F, Ruan C.
    J Thromb Haemost; 2007 Sep; 5(9):1963-70. PubMed ID: 17723136
    [Abstract] [Full Text] [Related]

  • 3. Generation and characterization of a recombinant single chain Fv antibody to von Willebrand factor A1 domain from phage display library.
    Zhu H, Wang Y, Jiang M, Ji S, Bai X, Ruan C.
    Thromb Res; 2005 Sep; 116(5):385-91. PubMed ID: 16122551
    [Abstract] [Full Text] [Related]

  • 4. Anti-human VWF monoclonal antibody SZ-123 prevents arterial thrombus formation by inhibiting VWF-collagen and VWF-platelet interactions in Rhesus monkeys.
    Zhao YM, Jiang M, Ji SD, He Y, Shen F, Li XM, Ruan CG.
    Biochem Pharmacol; 2013 Apr 01; 85(7):945-53. PubMed ID: 23295157
    [Abstract] [Full Text] [Related]

  • 5. A3 domain is essential for interaction of von Willebrand factor with collagen type III.
    Lankhof H, van Hoeij M, Schiphorst ME, Bracke M, Wu YP, Ijsseldijk MJ, Vink T, de Groot PG, Sixma JJ.
    Thromb Haemost; 1996 Jun 01; 75(6):950-8. PubMed ID: 8822592
    [Abstract] [Full Text] [Related]

  • 6. [Development of a monoclonal antibody to factor VIII C2 domain and its functional study].
    Li ZY, Zhao YM, Dong NZ, Shen F, Ruan CG.
    Zhonghua Xue Ye Xue Za Zhi; 2009 Mar 01; 30(3):154-7. PubMed ID: 19642361
    [Abstract] [Full Text] [Related]

  • 7. [Identification of the epitope of von Willebrand factor recognized by monoclonal antibody SZ-125 with immune-affinity mass spectrometry].
    Li X, Wang F, Shen F, Zhao Y, Jiang M.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Mar 01; 29(3):284-6. PubMed ID: 23643086
    [Abstract] [Full Text] [Related]

  • 8. Epitope mapping of inhibitory monoclonal antibodies to human von Willebrand factor by using recombinant cDNA libraries.
    Piétu G, Ribba AS, Chérel G, Siguret V, Obert B, Rouault C, Ginsburg D, Meyer D.
    Thromb Haemost; 1994 Jun 01; 71(6):788-92. PubMed ID: 7974349
    [Abstract] [Full Text] [Related]

  • 9. The chimeric monoclonal antibody MHCSZ-123 against human von Willebrand factor A3 domain inhibits high-shear arterial thrombosis in a Rhesus monkey model.
    Ji S, Jiang M, Yan B, Shen F, He Y, Wan A, Xia L, Ruan C, Zhao Y.
    J Hematol Oncol; 2017 May 19; 10(1):111. PubMed ID: 28526067
    [Abstract] [Full Text] [Related]

  • 10. Binding of von Willebrand factor to collagen type III: role of specific amino acids in the collagen binding domain of vWF and effects of neighboring domains.
    van der Plas RM, Gomes L, Marquart JA, Vink T, Meijers JC, de Groot PG, Sixma JJ, Huizinga EG.
    Thromb Haemost; 2000 Dec 19; 84(6):1005-11. PubMed ID: 11154106
    [Abstract] [Full Text] [Related]

  • 11. Sequence alignment between vWF and peptides inhibiting the vWF-collagen interaction does not result in the identification of a collagen-binding site in vWF.
    Vanhoorelbeke K, van der Plas RM, Vandecasteele G, Vauterin S, Huizinga EG, Sixma JJ, Deckmyn H.
    Thromb Haemost; 2000 Oct 19; 84(4):621-5. PubMed ID: 11057860
    [Abstract] [Full Text] [Related]

  • 12. Development of antibodies that interfere with the collagen-VWF-GPIb axis as new antithrombotics.
    Deckmyn H, Cauwenberghs N, Wu D, Depraetere H, Vanhoorelbeke K.
    Verh K Acad Geneeskd Belg; 2005 Oct 19; 67(1):55-65. PubMed ID: 15828307
    [Abstract] [Full Text] [Related]

  • 13. [Expression of the metalloproteinase domain of von Willebrand factor-cleaving protease and preparation of its McAb].
    Gao WQ, Shen F, Su J, Bai X, Ruan CG.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug 19; 13(4):537-41. PubMed ID: 16129029
    [Abstract] [Full Text] [Related]

  • 14. Epitope mapping of human VWF A3 recognized by monoclonal antibody SZ-123 and SZ-125 using MALDI mass spectrometry.
    Jiang M, Zhao Y, Shen F, Wang F, He Y, Ruan C.
    Int J Hematol; 2011 Sep 19; 94(3):241-247. PubMed ID: 21822587
    [Abstract] [Full Text] [Related]

  • 15. von Willebrand factor binds to native collagen VI primarily via its A1 domain.
    Hoylaerts MF, Yamamoto H, Nuyts K, Vreys I, Deckmyn H, Vermylen J.
    Biochem J; 1997 May 15; 324 ( Pt 1)(Pt 1):185-91. PubMed ID: 9164855
    [Abstract] [Full Text] [Related]

  • 16. Humanization by variable domain resurfacing and grafting on a human IgG4, using a new approach for determination of non-human like surface accessible framework residues based on homology modelling of variable domains.
    Staelens S, Desmet J, Ngo TH, Vauterin S, Pareyn I, Barbeaux P, Van Rompaey I, Stassen JM, Deckmyn H, Vanhoorelbeke K.
    Mol Immunol; 2006 Mar 15; 43(8):1243-57. PubMed ID: 16118019
    [Abstract] [Full Text] [Related]

  • 17. [Expression of von willebrand factor-A3 domain in E coli and its biological function].
    Zhu HP, Wang YC, Ji SD, Bai X, Jiang M, Ruan CG.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Apr 15; 12(2):199-203. PubMed ID: 15157333
    [Abstract] [Full Text] [Related]

  • 18. The role of VWF in the immunogenicity of FVIII.
    Lacroix-Desmazes S, Repessé Y, Kaveri SV, Dasgupta S.
    Thromb Res; 2008 Apr 15; 122 Suppl 2():S3-6. PubMed ID: 18549909
    [Abstract] [Full Text] [Related]

  • 19. Experimental indication for the existence of multiple Trp rotamers in von Willebrand Factor A3 domain.
    Hellings M, Engelborghs Y, Deckmyn H, Vanhoorelbeke K, Schiphorst ME, Akkerman JW, De Maeyer M.
    Proteins; 2004 Nov 15; 57(3):596-601. PubMed ID: 15382239
    [Abstract] [Full Text] [Related]

  • 20. Monoclonal antibodies that inhibit binding of propolypeptide of von Willebrand factor to collagen. Localization of epitopes.
    Fujisawa T, Takagi J, Sekiya F, Goto A, Miake F, Saito Y.
    Eur J Biochem; 1991 Mar 28; 196(3):673-7. PubMed ID: 1707363
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.